ABT-594
| CAS No. | 198283-73-7 | Cat. No. | BCP19181 |
| Name | ABT-594 | ||
| Synonyms | ABT594;ABT 594;Tebanicline;Ebanicline; | ||
| Formula | C9H11ClN2O | M. Wt | 198.652 |
| Description | Tebanicline, also known as ABT-594 and Ebanicline, a potent synthetic nicotinic (non-opioid) analgesic drug developed by Abbott. It was developed as a less toxic analogue of the potent poison dart frog-derived compound epibatidine, which is some 200x stronger than morphine as an analgesic but produces extremely dangerous toxic side effects. Like epibatidine, tebanicline showed potent analgesic activity against neuropathic pain in both animal and human trials, but with far less toxicity than its parent compound. It acts as a partial agonist at neuronal nicotinic acetylcholine receptors, binding to both the α3β4 and the α4β2 subtypes. | ||
| Related Products | 203564-54-9（Tebanicline HCl） 209326-19-2（Tebanicline dihydrochloride） 209326-18-1（Tebanicline benzoate） 198283-74-8（Tebanicline tosylate） | ||
| Pathways | Neuro Signaling Pathway | ||
| Targets | nAChR | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.